Sol Operating Margin from 2010 to 2026
| SLGL Stock | USD 63.50 4.50 7.63% |
Check Sol Gel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sol Gel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 254.6 K, Interest Expense of 1.6 M or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 24.53, Dividend Yield of 0.0 or PTB Ratio of 8.49. Sol financial statements analysis is a perfect complement when working with Sol Gel Valuation or Volatility modules.
Sol | Operating Margin | Build AI portfolio with Sol Stock |
Latest Sol Gel's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Sol Gel Technologies over the last few years. It is Sol Gel's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sol Gel's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.65 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Sol Operating Margin Regression Statistics
| Arithmetic Mean | (102.50) | |
| Coefficient Of Variation | (95.63) | |
| Mean Deviation | 93.15 | |
| Median | (181.80) | |
| Standard Deviation | 98.02 | |
| Sample Variance | 9,608 | |
| Range | 261 | |
| R-Value | 0.81 | |
| Mean Square Error | 3,539 | |
| R-Squared | 0.65 | |
| Significance | 0.000084 | |
| Slope | 15.70 | |
| Total Sum of Squares | 153,720 |
Sol Operating Margin History
About Sol Gel Financial Statements
Sol Gel investors utilize fundamental indicators, such as Operating Margin, to predict how Sol Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel. Sol-Gel Technologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 53 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Sol Gel Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sol Gel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 4.876 | Earnings Share (1.22) | Revenue Per Share | Quarterly Revenue Growth 2.177 | Return On Assets |
Investors evaluate Sol Gel Technologies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sol Gel's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Sol Gel's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sol Gel's market price signifies the transaction level at which participants voluntarily complete trades.